Found 620 matching trials
Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) PHASE2 The purpose of this study is to evaluate the safety and efficacy of pembrol...
Show More Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Learn More & Join Trial
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma PHASE1 The goal of the Phase I part of this clinical research study is to find the...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease) PHASE2 This study is a prospective cohort clinical trial that aims to investigate ...
Show More Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Learn More & Join Trial
A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma PHASE2 The purpose of this study is to test see the combined effects of the study ...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC. PHASE2 This study is a multicenter, prospective, randomized, double-arm, Phase II ...
Show More Location
Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy PHASE2 This phase II/III trial studies how well daunorubicin and cytarabine with o...
Show More Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Learn More & Join Trial
NSCLC Isotoxic Hypofractionated Chemoradiotherapy NA Radiotherapy plays an important role in non-small cell lung cancer (NSCLC),...
Show More Location
The Second Hospital of Hebei Medical University
Learn More & Join Trial
A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy PHASE2 This study aims to evaluate the efficacy and safety of adebrelimab consolid...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Liposomal Irinotecan, Capecitabine and Enlonstobart With Short-Course Radiotherapy for Locally Advanced Rectal Cancer PHASE2 This is a prospective, single-center, single-arm study evaluating the combi...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial